Skip to main content

Table 2 Maximum grade of toxicities per patient

From: A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancer

 

Grades 1/2

N (%)

Grades 3/4

N (%)

Anemia

8 (22.9)

4 (11.4)

Neutropenia

6 (17.1)

0

Thrombocytopenia

4 (11.4)

1 (2.9)

Alopecia

26 (74.3)

0

Fatigue

6 (17.1)

0

Nausea

4 (11.4)

0

Anorexia

5 (14.3)

0

Peripheral neuropathy

8 (22.9)

0

Stomatitis

7 (20)

0

Diarrhea

3 (8.6)

1 (2.9)

Constipation

11 (31.4)

0

Skin

9 (25.7)

0

Nail changes

15 (42.9)

0